Clinical Trial

SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCC

Name: SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCC — clinical trial record (NCT07758621)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is a randomized, controlled, open-label, multicenter phase III clinical trial, which aims to evaluate the efficacy, safety of SYS6010 compared with monotherapy in participants with HNSCC.

Trial Details

NCT Number	NCT07758621
Lead Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions	Head and Neck Squamous Cell Carcinoma
Enrollment	340 participants
Start Date	2026-08-15
Primary Completion	2028-09-15 (estimated)
Study Completion	2028-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11